USF’s Juan Carlos Cardet was among a team of researchers that found that 46 percent of black children with poorly controlled asthma fare better by increasing their dose of inhaled steroid instead of adding a long-acting beta-agonist to their regimen. The work was part of the multi-site Best African American Response to Asthma Drugs clinical study.
Physicians often recommend adding a LABA to the regimen for children with severe and poorly controlled asthma. Cardet says that this standard was based on studies that historically included too few black individuals, who suffer higher rates of serious asthma attacks, hospitalizations, and asthma-related deaths than white individuals.
View Related Expert Profiles: Go to Source
